297 389

Cited 30 times in

Effects of pregnane X receptor (NR1I2) and CYP2B6 genetic polymorphisms on the induction of bupropion hydroxylation by rifampin.

Authors
 Jae Yong Chung  ;  Joo-Youn Cho  ;  Hyeong-Seok Lim  ;  Jung-Ryul Kim  ;  Kyung-Sang Yu  ;  Kyoung Soo Lim  ;  Sang-Goo Shin  ;  In-Jin Jang 
Citation
 DRUG METABOLISM AND DISPOSITION, Vol.39(1) : 92-97, 2011 
Journal Title
DRUG METABOLISM AND DISPOSITION
ISSN
 0090-9556 
Issue Date
2011
MeSH
Aryl Hydrocarbon Hydroxylases/genetics* ; Aryl Hydrocarbon Hydroxylases/metabolism ; Asian Continental Ancestry Group/genetics ; Bupropion/analogs & derivatives* ; Bupropion/blood ; Bupropion/metabolism* ; Cytochrome P-450 CYP2B6 ; Drug Interactions ; Female ; Genotype ; Humans ; Hydroxylation ; Male ; Oxidoreductases, N-Demethylating/genetics* ; Oxidoreductases, N-Demethylating/metabolism ; Polymorphism, Single Nucleotide* ; Receptors, Steroid/genetics* ; Receptors, Steroid/metabolism ; Rifampin/pharmacology*
Abstract
We investigated genetic polymorphisms in the pregnane X receptor (NR1I2) in Korean individuals (n = 83) and the effects of NR1I2 genotypes on rifampin-mediated induction of bupropion hydroxylation. The pharmacokinetics of bupropion and hydroxybupropion were evaluated after an oral dose of bupropion (150 mg) administered before and after rifampin treatment for 7 days in 35 healthy subjects. The area under the time-concentration curve (AUC) ratio of hydroxybupropion to bupropion in CYP2B6*6 carriers was significantly lower than that in CYP2B6*6 noncarriers in both the basal and rifampin-induced states (p = 0.012). Among the CYP2B6*6 carriers (n = 13), the NR1I2 TGT (-25385T + g.7635G + g.8055T) carriers exhibited a significantly lower AUC ratio, representing the CYP2B6 hydroxylation activity, compared with the TGT noncarriers, in the induced state (11.9 versus 20.3, p = 0.045). The percent difference in the AUC ratio between the basal and induced states was also significantly different (212% versus 58.8%, p = 0.006). However, no significant difference was observed among the NR1I2 TGT genotypes for the CYP2B6*6 noncarriers (n = 22). In conclusion, it is suggested the NR1I2 TGT genotype decreases the bupropion hydroxylation induced by treatment with rifampin, particularly in CYP2B6*6 carriers.
Files in This Item:
T201100243.pdf Download
DOI
10.1124/dmd.110.035246
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers
Yonsei Authors
Chung, Jae Yong(정재용)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/92613
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links